BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 36810281)

  • 1. Emerging roles of m6A RNA modification in cancer therapeutic resistance.
    Liu WW; Zhang ZY; Wang F; Wang H
    Exp Hematol Oncol; 2023 Feb; 12(1):21. PubMed ID: 36810281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
    Liu WW; Wang H; Zhu XY
    Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications.
    Mao Z; Wang B; Zhang T; Cui B
    Cell Death Dis; 2023 Nov; 14(11):734. PubMed ID: 37951987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
    Fang X; Li M; Yu T; Liu G; Wang J
    Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of N6-methyladenosine modification in the development of Parkinson's disease.
    Zhou J; Han Y; Hou R
    Front Cell Dev Biol; 2023; 11():1321995. PubMed ID: 38155838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development.
    Liu S; Chen S; Tang C; Zhao Y; Cui W; Jia L; Wang L
    Front Oncol; 2022; 12():970833. PubMed ID: 36226062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours.
    Xia Z; Kong F; Wang K; Zhang X
    Front Pharmacol; 2022; 13():908079. PubMed ID: 35754499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging importance role of m6A modification in liver disease.
    Wang S; Gao S; Ye W; Li Y; Luan J; Lv X
    Biomed Pharmacother; 2023 Jun; 162():114669. PubMed ID: 37037093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.
    Xu Z; Peng B; Cai Y; Wu G; Huang J; Gao M; Guo G; Zeng S; Gong Z; Yan Y
    Biochem Pharmacol; 2020 Dec; 182():114258. PubMed ID: 33017575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
    Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
    Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance.
    Jo H; Shim K; Jeoung D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer.
    Qiao H; Liu L; Chen J; Shang B; Wang L
    Med Oncol; 2022 Sep; 39(12):235. PubMed ID: 36175777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy.
    Shriwas O; Mohapatra P; Mohanty S; Dash R
    Front Oncol; 2020; 10():612337. PubMed ID: 33718113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis.
    Zhai G; Xiao L; Jiang C; Yue S; Zhang M; Zheng J; Liu Z; Dong Y
    Front Cell Dev Biol; 2022; 10():946219. PubMed ID: 35846376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of m6A methylation modification in ovarian cancer.
    Chang LL; Xu XQ; Liu XL; Guo QQ; Fan YN; He BX; Zhang WZ
    Cancer Cell Int; 2021 Dec; 21(1):663. PubMed ID: 34895230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
    Imam H; Kim GW; Siddiqui A
    Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.